Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIR-ICG Imaging of Lymphatic Transport
NCT02680067Phase 1Completed
- Sponsor
- University of Rochester
- Start
- Dec 2015
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of indocyanine green (2 arms), sponsored by University of Rochester. Primary endpoint: Lymphatic Contraction Rate at 36 months. Started Dec 2015; status: completed.
02
Drugs
indocyanine green
Beyond the preview
Go deeper on NCT02680067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680067.